 Jason Northey, PhD
|
|
| Title | Postdoctoral Scholar |
|---|
| School | UCSF School of Medicine |
|---|
| Department | Surgery |
|---|
| Address | 3333 Calif. St,Laurel Heights
San Francisco CA 94118
|
|---|
| vCard | Download vCard |
|---|
|
|
 Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
Researchers can login to make corrections and additions, or contact us for help.
-
Northcott JM, Northey J, Barnes JM, Weaver VM. Fighting the force: Potential of homeobox genes for tumor microenvironment regulation. Biochim Biophys Acta. 2015 Apr; 1855(2):248-53. PMID: 25818365; PMCID: PMC4433566 [Available on 04/01/16].
-
Ngan E, Northey J, Brown CM, Ursini-Siegel J, Siegel PM. A complex containing LPP and a-actinin mediates TGFß-induced migration and invasion of ErbB2-expressing breast cancer cells. J Cell Sci. 2013 May 1; 126(Pt 9):1981-91. PMID: 23447672; PMCID: PMC3791827.
-
Northey J, Dong Z, Ngan E, Kaplan A, Hardy WR, Pawson T, Siegel PM. Distinct phosphotyrosine-dependent functions of the ShcA adaptor protein are required for transforming growth factor ß (TGFß)-induced breast cancer cell migration, invasion, and metastasis. J Biol Chem. 2013 Feb 15; 288(7):5210-22. PMID: 23277357; PMCID: PMC3576125.
-
Northey J, Chmielecki J, Ngan E, Russo C, Annis MG, Muller WJ, Siegel PM. Signaling through ShcA is required for transforming growth factor beta- and Neu/ErbB-2-induced breast cancer cell motility and invasion. Mol Cell Biol. 2008 May; 28(10):3162-76. PMID: 18332126; PMCID: PMC2423163.
-
Mourskaia AA, Northey J, Siegel PM. Targeting aberrant TGF-beta signaling in pre-clinical models of cancer. Anticancer Agents Med Chem. 2007 Sep; 7(5):504-14. PMID: 17896911.
|
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Related Authors People who share related concepts with this person. _
|
